← FDA Drug Approvals (Drugs@FDA)

GABAPENTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS · Approved 2012-03-23

Drug application

FDA Application #

ANDA202024

Application type

Abbreviated New Drug Application (Generic)

Brand name

GABAPENTIN

Generic name

GABAPENTIN

Active ingredients

GABAPENTIN

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

AMNEAL PHARMS

Manufacturer

Amneal Pharmaceuticals LLC

First approval

2012-03-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown